Blue Owl Capital Holdings
Latest statistics and disclosures from Blue Owl Capital Holdings's latest quarterly 13F-HR filing:
- Top 5 stock holdings are CGEM, PLRX, OBDC, KVYO, LRMR, and represent 43.73% of Blue Owl Capital Holdings's stock portfolio.
- Added to shares of these 10 stocks: CNTX (+$10M), VKTX (+$5.0M), STWD, PYXS, TRML, MREO, IRON, GPCR, JANX, CELC.
- Started 11 new stock positions in GERN, GPCR, Desktop Metal, JANX, PYXS, VKTX, PLMJU, MREO, STWD, CELC. CNTX.
- Reduced shares in these 10 stocks: HOOD (-$54M), CGEM (-$15M), ENGNW (-$5.5M), MLTX (-$5.0M), DELL, LABD, MDGL, BDTX, OVID, BRZE.
- Sold out of its positions in BDTX, BRZE, DELL, Desktop Metal Inc Com Cl A, LABD, ELVN, Fathom Digital Mfg Corp, GTLB, MDGL, MLTX. OVID, RLYB, HOOD, SNOW, UBER.
- Blue Owl Capital Holdings was a net seller of stock by $-68M.
- Blue Owl Capital Holdings has $360M in assets under management (AUM), dropping by -28.17%.
- Central Index Key (CIK): 0001858703
Tip: Access up to 7 years of quarterly data
Positions held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Blue Owl Capital Holdings
Blue Owl Capital Holdings holds 41 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Cullinan Oncology (CGEM) | 9.9 | $36M | -29% | 2.0M | 17.44 |
|
| Pliant Therapeutics (PLRX) | 9.0 | $32M | 3.0M | 10.75 |
|
|
| Owl Rock Capital Corporation (OBDC) | 8.7 | $31M | 2.0M | 15.36 |
|
|
| Klaviyo Com Ser A (KVYO) | 8.3 | $30M | 1.2M | 24.89 |
|
|
| Larimar Therapeutics (LRMR) | 7.8 | $28M | -3% | 3.9M | 7.25 |
|
| Engene Holdings (ENGN) | 6.4 | $23M | 2.4M | 9.43 |
|
|
| Tourmaline Bio (TRML) | 6.1 | $22M | +18% | 1.7M | 12.86 |
|
| Evercommerce (EVCM) | 5.0 | $18M | 1.6M | 10.98 |
|
|
| Acelyrin (SLRN) | 3.6 | $13M | +3% | 2.9M | 4.41 |
|
| Repare Therapeutics Ord (RPTX) | 3.1 | $11M | +8% | 3.4M | 3.30 |
|
| Ultragenyx Pharmaceutical (RARE) | 3.1 | $11M | 268k | 41.10 |
|
|
| Context Therapeutics (CNTX) | 2.9 | $10M | NEW | 5.2M | 2.00 |
|
| Disc Medicine (IRON) | 2.7 | $9.7M | +38% | 215k | 45.07 |
|
| Toast Cl A (TOST) | 2.3 | $8.3M | 323k | 25.77 |
|
|
| E2open Parent Holdings Com Cl A (ETWO) | 2.1 | $7.4M | 1.7M | 4.49 |
|
|
| Keros Therapeutics (KROS) | 2.0 | $7.2M | -8% | 158k | 45.70 |
|
| Ikena Oncology (IKNA) | 1.9 | $6.8M | +5% | 4.1M | 1.65 |
|
| Sagimet Biosciences Com Ser A (SGMT) | 1.6 | $5.7M | 1.7M | 3.42 |
|
|
| Mineralys Therapeutics (MLYS) | 1.5 | $5.3M | -16% | 450k | 11.70 |
|
| Viking Therapeutics (VKTX) | 1.4 | $5.0M | NEW | 95k | 53.01 |
|
| Inozyme Pharma (INZY) | 1.4 | $5.0M | -11% | 1.1M | 4.46 |
|
| Starwood Property Trust SHS (STWD) | 1.2 | $4.3M | NEW | 227k | 18.94 |
|
| Pyxis Oncology Common Stock (PYXS) | 1.0 | $3.5M | NEW | 1.0M | 3.31 |
|
| Mereo Biopharma Group Spon Ads (MREO) | 0.9 | $3.2M | NEW | 898k | 3.60 |
|
| Aquestive Therapeutics (AQST) | 0.8 | $3.0M | +30% | 1.1M | 2.60 |
|
| Compass Therapeutics (CMPX) | 0.8 | $2.8M | 2.8M | 1.00 |
|
|
| Adc Therapeutics Sa SHS (ADCT) | 0.6 | $2.3M | 734k | 3.16 |
|
|
| Omega Therapeutics Common Stock (OMGA) | 0.6 | $2.2M | 1.1M | 2.07 |
|
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.6 | $2.2M | NEW | 55k | 39.27 |
|
| Immunovant (IMVT) | 0.6 | $2.1M | -20% | 80k | 26.40 |
|
| Syros Pharmaceuticals Com New (SYRS) | 0.5 | $1.8M | 341k | 5.16 |
|
|
| Janux Therapeutics (JANX) | 0.5 | $1.7M | NEW | 40k | 41.89 |
|
| Celcuity (CELC) | 0.3 | $1.1M | NEW | 65k | 16.38 |
|
| Blend Labs Cl A (BLND) | 0.2 | $853k | 362k | 2.36 |
|
|
| Gohealth Cl A New (GOCO) | 0.2 | $815k | 83k | 9.78 |
|
|
| Engene Holdings *w Exp 10/31/202 (ENGNW) | 0.2 | $608k | -89% | 51k | 11.89 |
|
| Plum Acquisition Corp Iii Unit 03/31/2028 (PLMJU) | 0.1 | $324k | NEW | 70k | 4.63 |
|
| Desktop Metal Com Cl A | 0.1 | $310k | NEW | 750k | 0.41 |
|
| Precision Biosciences Com New (DTIL) | 0.1 | $197k | 20k | 9.73 |
|
|
| Geron Corporation (GERN) | 0.0 | $101k | NEW | 24k | 4.24 |
|
| Plum Acquisition Corp Iii *w Exp 03/31/202 (PLMJW) | 0.0 | $47k | 667k | 0.07 |
|
Past Filings by Blue Owl Capital Holdings
SEC 13F filings are viewable for Blue Owl Capital Holdings going back to 2021
- Blue Owl Capital Holdings 2024 Q2 filed Aug. 15, 2024
- Blue Owl Capital Holdings 2024 Q1 filed May 15, 2024
- Blue Owl Capital Holdings 2023 Q4 filed Feb. 15, 2024
- Blue Owl Capital Holdings 2023 Q3 filed Nov. 14, 2023
- Blue Owl Capital Holdings 2023 Q2 filed Aug. 11, 2023
- Blue Owl Capital Holdings 2023 Q1 filed May 11, 2023
- Blue Owl Capital Holdings 2022 Q4 filed Feb. 13, 2023
- Blue Owl Capital Holdings 2022 Q3 filed Nov. 14, 2022
- Blue Owl Capital Holdings 2022 Q2 filed Aug. 12, 2022
- Blue Owl Capital Holdings 2021 Q4 restated filed May 16, 2022
- Blue Owl Capital Holdings 2021 Q4 amended filed May 16, 2022
- Blue Owl Capital Holdings 2022 Q1 filed May 16, 2022
- Blue Owl Capital Holdings 2021 Q4 filed Feb. 11, 2022